Technical Analysis for PTHL - Pheton Holdings Ltd
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| C | 4.90 | -1.61% | -0.08 |
PTHL closed up 9.45 percent on Wednesday, November 20, 2024, on 35 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 50 DMA | Bullish | -1.61% | |
| MACD Bullish Centerline Cross | Bullish | -1.61% | |
| Stochastic Reached Overbought | Strength | -1.61% | |
| Above Upper BB | Strength | -1.61% | |
| Overbought Stochastic | Strength | -1.61% | |
| Upper Bollinger Band Touch | Strength | -1.61% | |
| Fell Below 50 DMA | Bearish | 7.69% | |
| 20 DMA Support | Bullish | 7.69% | |
| Crossed Above 50 DMA | Bullish | 5.60% | |
| Crossed Above 20 DMA | Bullish | 12.64% |
| Alert | Time |
|---|---|
| Down 1% | about 2 hours ago |
| Up 1% | about 2 hours ago |
| Fell Below Upper Bollinger Band | about 2 hours ago |
| 50 DMA Support | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD
Sector: Healthcare
Industry: Medical Devices
Keywords: Cancer Tumor Radiation Radiation Therapy Medical Physics Healthcare Solution Brachytherapy Malignant Tumors
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Cancer Tumor Radiation Radiation Therapy Medical Physics Healthcare Solution Brachytherapy Malignant Tumors
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.45 |
| 52 Week Low | 3.32 |
| Average Volume | 208,005 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 4.67 |
| 20-Day Moving Average | 4.31 |
| 10-Day Moving Average | 4.42 |
| Average True Range | 0.50 |
| RSI (14) | 57.45 |
| ADX | 16.1 |
| +DI | 21.62 |
| -DI | 13.23 |
| Chandelier Exit (Long, 3 ATRs) | 3.59 |
| Chandelier Exit (Short, 3 ATRs) | 5.04 |
| Upper Bollinger Bands | 4.88 |
| Lower Bollinger Band | 3.75 |
| Percent B (%b) | 1.09 |
| BandWidth | 26.28 |
| MACD Line | 0.01 |
| MACD Signal Line | -0.07 |
| MACD Histogram | 0.0773 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.68 | ||||
| Resistance 3 (R3) | 5.65 | 5.37 | 5.57 | ||
| Resistance 2 (R2) | 5.37 | 5.19 | 5.39 | 5.53 | |
| Resistance 1 (R1) | 5.18 | 5.08 | 5.27 | 5.21 | 5.49 |
| Pivot Point | 4.90 | 4.90 | 4.95 | 4.92 | 4.90 |
| Support 1 (S1) | 4.71 | 4.72 | 4.81 | 4.75 | 4.47 |
| Support 2 (S2) | 4.43 | 4.61 | 4.45 | 4.43 | |
| Support 3 (S3) | 4.24 | 4.43 | 4.39 | ||
| Support 4 (S4) | 4.28 |
